Drug Safety Matters

44 Episodes

1. #29 When medicines change our behaviour – Michele Fusaroli

   Published: 4/23/2024
2. #28 Catching black swans – François Montastruc

   Published: 2/29/2024
3. #27 When drugs damage the liver – Rita Baião

   Published: 2/1/2024
4. #26 What's trending in pharmacovigilance? – Angela Caro

   Published: 12/20/2023
5. #25 A week in the name of medicines safety – part 2

   Published: 11/13/2023
6. #24 A week in the name of medicines safety – part 1

   Published: 11/2/2023
7. Uppsala Reports Long Reads – The colour of signals

   Published: 9/29/2023
8. Uppsala Reports Long Reads – Empowering patients as partners

   Published: 9/5/2023
9. #23 Assessing safety in clinical trials – Marianne Lunzer & Sanja Prpić

   Published: 6/27/2023
10. #22 Reforming pharmacovigilance education – Michael Reumerman

    Published: 5/8/2023
11. #21 Unlocking the power of real-world data – Patrick Ryan

    Published: 3/30/2023
12. #20 The evidence for signals – Daniele Sartori

    Published: 2/23/2023
13. Uppsala Reports Long Reads – Unmasking data in the COVID-19 vaccine era

    Published: 1/26/2023
14. #19 Lessons in pandemic pharmacovigilance – Elena Rocca

    Published: 12/15/2022
15. #18 The IDMP standards explained – Malin Fladvad & Olle Lagerlund

    Published: 9/29/2022
16. #17 Why we need vaccine surveillance systems – Madhava Balakrishnan

    Published: 8/24/2022
17. #16 How drug safety can help fight resistant bugs – Jean Marie Vianney Habarugira & Albert Figueras

    Published: 6/30/2022
18. #15 Safety of HIV medications – Henry Zakumumpa

    Published: 4/29/2022
19. #14 Advancing pharmacovigilance in Africa – Eleni Aklillu & Abbie Barry

    Published: 3/24/2022
20. #13 How to talk about risks – Alexandra Freeman

    Published: 2/24/2022